{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:13:55Z","timestamp":1783098835998,"version":"3.54.6"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T00:00:00Z","timestamp":1653264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Angiotensin-converting enzyme (ACE) as an important enzyme in the renin-angiotensin system facilitates biogenesis of the functionally active product angiotensin II from angiotensin I. <jats:italic>ACE<\/jats:italic> gene contains a number of functional polymorphisms which modulate activity of the encoded protein. In the current case\u2013control study, we appraised the association between the rs4359 and rs1799752 polymorphisms and risk of bipolar disorder (type I and type II; BPDI and BPDII), schizophrenia (SCZ) and obsessive\u2013compulsive disorder (OCD). The rs4359 was associated with risk of OCD, BPDI and BPDII in co-dominant and dominant models. The rs1799752 was associated with all assessed psychiatric conditions in four inheritance models except for BPDII whose association was not significant in recessive model. The I allele of rs1799752 was associated with OCD (adjusted FDR q-Value\u2009=\u20094.04E-04), SCZ (adjusted FDR q-Value\u2009=\u20096.00E-06), BPDI (adjusted FDR q-Value\u2009=\u20098.40E-03) and BPDII (adjusted FDR q-Value\u2009=\u20096.00E-06). The effective T allele of rs4359 showed a significant association with disease risk for BPDII group. The estimated haplotypes of these polymorphisms have been distributed differently among patients and controls. Taken together, <jats:italic>ACE<\/jats:italic> polymorphisms can be regarded as risk factors for a variety of psychiatric disorders.<\/jats:p>","DOI":"10.1186\/s12888-022-04007-w","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T20:33:39Z","timestamp":1653338019000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Angiotensin I converting enzyme gene polymorphisms and risk of psychiatric disorders"],"prefix":"10.1186","volume":"22","author":[{"given":"Mohammadarian","family":"Akbari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhane","family":"Eghtedarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashdar Mahmud","family":"Hussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solat","family":"Eslami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Taheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soudeh","family":"Ghafouri-Fard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,23]]},"reference":[{"issue":"3","key":"4007_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/pr.59.3.3","volume":"59","author":"H Kobori","year":"2007","unstructured":"Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev. 2007;59(3):251\u201387.","journal-title":"Pharmacol Rev"},{"key":"4007_CR2","doi-asserted-by":"crossref","unstructured":"Sibony M, Gasc J-M, Soubrier F, Alhenc-Gelas F, Corvol P. Gene expression and tissue localization of the two isoforms of angiotensin I converting enzyme. Hypertension. 1993;21(6_pt_1):827\u201335.","DOI":"10.1161\/01.HYP.21.6.827"},{"issue":"9","key":"4007_CR3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/jnr.23404","volume":"92","author":"S Liu","year":"2014","unstructured":"Liu S, Liu J, Miura Y, Tanabe C, Maeda T, Terayama Y, et al. Conversion of A\u03b243 to A\u03b240 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme. J Neurosci Res. 2014;92(9):1178\u201386.","journal-title":"J Neurosci Res"},{"issue":"4","key":"4007_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.31887\/DCNS.2006.8.4\/mising","volume":"8","author":"M Ising","year":"2006","unstructured":"Ising M, Holsboer F. Genetics of stress response and stress-related disorders. Dialogues Clin Neurosci. 2006;8(4):433.","journal-title":"Dialogues Clin Neurosci"},{"issue":"9","key":"4007_CR5","first-page":"502","volume":"300","author":"A Arregui","year":"1979","unstructured":"Arregui A, MacKay A, Iversen L, Spokes E. Reduction of angiotensin-converting enzyme in substantia nigra in early-onset schizophrenia. N Engl J Med. 1979;300(9):502\u20133.","journal-title":"N Engl J Med"},{"issue":"9","key":"4007_CR6","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1056\/NEJM198008283030920","volume":"303","author":"F Owen","year":"1980","unstructured":"Owen F, Lofthouse R, Crow T. Angiotensin-converting enzyme in substantia nigra of schizophrenics. N Engl J Med. 1980;303(9):528\u20139.","journal-title":"N Engl J Med"},{"key":"4007_CR7","unstructured":"Beckmann H, Saavedra JM, Gattaz WF. Low angiotensin-converting enzyme activity (kininase II) in cerebrospinal fluid of schizophrenics. Biological psychiatry. 1984."},{"key":"4007_CR8","unstructured":"Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American journal of psychiatry. 1991."},{"issue":"1","key":"4007_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00003495-199000391-00005","volume":"39","author":"CI Johnston","year":"1990","unstructured":"Johnston CI. Biochemistry and pharmacology of the renin-angiotensin system. Drugs. 1990;39(1):21\u201331.","journal-title":"Drugs"},{"key":"4007_CR10","doi-asserted-by":"crossref","unstructured":"Lieb K, Treffurth Y, Berger M, Fiebich BL. Substance P and affective disorders: new treatment opportunities by neurokinin 1 receptor antagonists? Neuropsychobiology. 2002;45 Suppl 1:2\u20136. PubMed PMID: 11893870. Epub 2002\/03\/15. eng.","DOI":"10.1159\/000049254"},{"issue":"22","key":"4007_CR11","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1007\/s00018-016-2293-z","volume":"73","author":"A Mashaghi","year":"2016","unstructured":"Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response. Cell Mol Life Sci. 2016;73(22):4249\u201364.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"4007_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psc.2006.12.005","volume":"30","author":"RC Shelton","year":"2007","unstructured":"Shelton RC. The molecular neurobiology of depression. Psychiatr Clin North Am. 2007;30(1):1\u201311.","journal-title":"Psychiatr Clin North Am"},{"key":"4007_CR13","doi-asserted-by":"crossref","unstructured":"Sanches M, Colpo GD, Cuellar VA, Bockmann T, Rogith D, Soares JC, et al. Decreased Plasma Levels of Angiotensin-Converting Enzyme Among Patients With Bipolar Disorder. Front Neurosci. 2021;15:617888-. PubMed PMID: 33642980. eng.","DOI":"10.3389\/fnins.2021.617888"},{"issue":"11","key":"4007_CR14","doi-asserted-by":"publisher","first-page":"e322-e","DOI":"10.1038\/tp.2013.95","volume":"3","author":"M-L Ancelin","year":"2013","unstructured":"Ancelin M-L, Carri\u00e8re I, Scali J, Ritchie K, Chaudieu I, Ryan J. Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression. Translational Psychiatry. 2013;3(11):e322-e.","journal-title":"Translational Psychiatry"},{"key":"4007_CR15","doi-asserted-by":"crossref","unstructured":"Bhatnagar V, O'Connor DT, Schork NJ, Salem RM, Nievergelt CM, Rana BK, et al. Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial. Journal of hypertension. 2007 Oct;25(10):2082\u201392. PubMed PMID: 17885551. Pubmed Central PMCID: PMC2792638. Epub 2007\/09\/22. eng.","DOI":"10.1097\/HJH.0b013e3282b9720e"},{"key":"4007_CR16","doi-asserted-by":"crossref","unstructured":"Teranishi J, Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Okada N, et al. ACE insertion\/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy. Journal of the renin-angiotensin-aldosterone system : JRAAS. 2015 Sep;16(3):633\u201341. PubMed PMID: 24452035. Epub 2014\/01\/24. eng.","DOI":"10.1177\/1470320313515036"},{"key":"4007_CR17","doi-asserted-by":"crossref","unstructured":"Ghorbani E, Mohammadi M, Malakouti SK, Mohammadi-Kangarani H, Abdollahi E, Torab M, et al. Association of ACE Gene Insertion\/Deletion Polymorphism with Suicidal Attempt in an Iranian Population. Biochemical genetics. 2021 Feb;59(1):31\u201341. PubMed PMID: 32720141. Epub 2020\/07\/29. eng.","DOI":"10.1007\/s10528-020-09986-7"},{"key":"4007_CR18","unstructured":"Diagnostic and statistical manual of mental disorders (Edition, Fifth). Am Psychiatric Assoc. 2013;21."},{"key":"4007_CR19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.intimp.2018.09.014","volume":"64","author":"R Yaeghmaie","year":"2018","unstructured":"Yaeghmaie R, Ghafouri-Fard S, Noroozi R, Tavakoli F, Taheri M, Ayatollahi SA. Polymorphisms in the angiotensin I converting enzyme (ACE) gene are associated with multiple sclerosis risk and response to interferon-\u03b2 treatment. Int Immunopharmacol. 2018;64:275\u20139.","journal-title":"Int Immunopharmacol"},{"key":"4007_CR20","doi-asserted-by":"crossref","unstructured":"Akbari M, Taheri M, Mehrpoor G, Eslami S, Hussen BM, Ghafouri-Fard S, et al. Assessment of ACE1 variants and ACE1\/ACE2 expression in COVID-19 patients. Vascul Pharmacol. 2022;142:106934-. PubMed PMID: 34774774. Epub 11\/10. eng.","DOI":"10.1016\/j.vph.2021.106934"},{"issue":"1","key":"4007_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1177\/0004867417721654","volume":"52","author":"DJ Brownstein","year":"2018","unstructured":"Brownstein DJ, Salagre E, K\u00f6hler C, Stubbs B, Vian J, Pereira C, et al. Blockade of the angiotensin system improves mental health domain of quality of life: A meta-analysis of randomized clinical trials. Aust N Z J Psychiatry. 2018;52(1):24\u201338.","journal-title":"Aust N Z J Psychiatry"},{"key":"4007_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.neubiorev.2019.11.024","volume":"108","author":"B Rodr\u00edguez","year":"2020","unstructured":"Rodr\u00edguez B, Nani JV, Almeida PG, Brietzke E, Lee RS, Hayashi MA. Neuropeptides and oligopeptidases in schizophrenia. Neurosci Biobehav Rev. 2020;108:679\u201393.","journal-title":"Neurosci Biobehav Rev"},{"issue":"12","key":"4007_CR23","doi-asserted-by":"publisher","first-page":"e691-e","DOI":"10.1038\/tp.2015.181","volume":"5","author":"A Gadelha","year":"2015","unstructured":"Gadelha A, Vendramini A, Yonamine C, Nering M, Berberian A, Suiama M, et al. Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia. Translational Psychiatry. 2015;5(12):e691-e.","journal-title":"Translational Psychiatry"},{"issue":"7","key":"4007_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040479","volume":"7","author":"P Zill","year":"2012","unstructured":"Zill P, Baghai TC, Sch\u00fcle C, Born C, Fr\u00fcst\u00fcck C, B\u00fcttner A, et al. DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression. PLoS ONE. 2012;7(7): e40479.","journal-title":"PLoS ONE"},{"key":"4007_CR25","doi-asserted-by":"crossref","unstructured":"Kibitov AA, Rakitko AS, Kasyanov ED, Rukavishnikov GV, Kozlova KA, Ilinsky VV, et al. Screening of Depressive Symptoms in a Russian General Population Sample: A Web-based Cross-sectional Study. Clin Pract Epidemiol Ment Health. 2021;17:205\u201311. PubMed PMID: 35173789. eng.","DOI":"10.2174\/1745017902117010205"},{"key":"4007_CR26","unstructured":"De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues in clinical neuroscience. 2022."},{"issue":"11","key":"4007_CR27","first-page":"1003","volume":"11","author":"T Baghai","year":"2006","unstructured":"Baghai T, Binder E, Schule C, Salyakina D, Eser D, Lucae S, et al. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression. ACE activity and hypercortisolism Molecular psychiatry. 2006;11(11):1003\u201315.","journal-title":"ACE activity and hypercortisolism Molecular psychiatry"},{"issue":"5","key":"4007_CR28","first-page":"885","volume":"28","author":"S Gulec-Yilmaz","year":"2014","unstructured":"Gulec-Yilmaz S, Gulec H, Dalan AB, Cetin B, Timirci-Kahraman O, Ogut DB, et al. The relationship between ACE polymorphism and panic disorder. In Vivo. 2014;28(5):885\u20139.","journal-title":"In Vivo"},{"key":"4007_CR29","unstructured":"Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. American journal of human genetics. 1992 Jul;51(1):197\u2013205. PubMed PMID: 1319114. Pubmed Central PMCID: PMC1682892. Epub 1992\/07\/01. eng."},{"issue":"7","key":"4007_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1080\/10641963.2018.1529782","volume":"41","author":"M Hristova","year":"2019","unstructured":"Hristova M, Stanilova S, Miteva L. Serum concentration of renin-angiotensin system components in association with ACE I\/D polymorphism among hypertensive subjects in response to ACE inhibitor therapy. Clin Exp Hypertens. 2019;41(7):662\u20139.","journal-title":"Clin Exp Hypertens"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-022-04007-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-022-04007-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:11:23Z","timestamp":1654168283000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-022-04007-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,23]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1186\/s12888-022-04007-w","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,23]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The email of the second corresponding author has been added. The article has been updated to rectify the error.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent forms were obtained from all study participants. The study protocol was approved by the ethical committee of Shahid Beheshti University of Medical Sciences (IR.SBMU.RETECH.REC.1400.320). All methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent of publication"}},{"value":"The authors declare they have no conflict of interest","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"351"}}